Chinese pharmaceutical companies are struggling to keep pace with surging demand at home and abroad for COVID-19 vaccines. “The problem is that it currently does not have enough production capacity to satisfy both domestic and international demand, which makes its vaccine diplomacy unsustainable at least in the coming two months,” said Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations in New York.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Connect with leading professionals on the China- Africa Experts Network.